Sign Up to like & get
recommendations!
1
Published in 2022 at "Pest management science"
DOI: 10.1002/ps.6984
Abstract: BACKGROUND Mosquito control is still the main prevention and control measure of numerous mosquito-borne diseases causing millions of deaths each year. New strategies for mosquito control are in demand. Proteases play an important role in…
read more here.
Keywords:
factor inhibitor;
control;
pipiserpin;
mosquito control ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of medical economics"
DOI: 10.1080/13696998.2022.2042106
Abstract: AIMS To conduct a cost-effectiveness analysis (CEA) on the use of andexanet alfa for the treatment of factor Xa inhibitor-related intracranial hemorrhage (ICH) from the United States (US) third-party payer and societal perspectives. METHODS CEA…
read more here.
Keywords:
cost;
treatment;
factor inhibitor;
factor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab092.004
Abstract: C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare, progressive kidney diseases requiring a biopsy for definite diagnosis. Both C3G and IC-MPGN are attributed to complement dysregulation, with dysregulation of the alternative pathway…
read more here.
Keywords:
biomarker;
c3g mpgn;
factor inhibitor;
characteristics patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.14353
Abstract: To evaluate the correlation of inflammatory cytokines with the treatment response to tumor necrosis factor inhibitor (TNFi) in axial spondyloarthritis (axSpA) patients.
read more here.
Keywords:
necrosis factor;
axial spondyloarthritis;
tumor necrosis;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13771
Abstract: Immune disorder is a key trigger of recurrent spontaneous abortion (RSA); meanwhile, tumour necrosis factor inhibitor (TNFi) is a fundamental therapeutic for multiple immune and inflammatory diseases. Hence, this real‐world study aimed to explore the…
read more here.
Keywords:
necrosis factor;
combined intravenous;
spontaneous abortion;
recurrent spontaneous ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pediatric dermatology"
DOI: 10.1111/pde.14993
Abstract: Tumor necrosis factor-α inhibitor-associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection-related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with…
read more here.
Keywords:
necrosis factor;
factor inhibitor;
tumor necrosis;
follicular psoriasiform ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Pharmacology"
DOI: 10.1159/000494059
Abstract: Background/Aims: Stent thrombosis is a serious complication after percutaneous coronary intervention and femoropopliteal endovascular intervention. The aim of this study was to determine the antithrombotic effects of a direct factor Xa inhibitor edoxaban alone or…
read more here.
Keywords:
prevention stent;
factor inhibitor;
stent thrombosis;
thrombosis ... See more keywords